Patents by Inventor Valentin Krinski

Valentin Krinski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10549108
    Abstract: A method for extinguishing a cardiac arrhythmia utilizes destructive interference of the passing of the reentry wave tip of an anatomical reentry through a depolarized region created by a relatively low voltage electric field in such a way as to effectively unpin the anatomical reentry. Preferably, the relatively low voltage electric field is defined by at least one unpinning shock(s) that are lower than an expected lower limit of vulnerability as established, for example, by a defibrillation threshold test. By understanding the physics of the electric field distribution between cardiac cells, the method permits the delivery of an electric field sufficient to unpin the core of the anatomical reentry, whether the precise or estimated location of the reentry is known or unknown and without the risk of inducting ventricular fibrillation. A number of embodiments for performing the method are disclosed.
    Type: Grant
    Filed: August 27, 2018
    Date of Patent: February 4, 2020
    Assignee: The Washington University
    Inventors: Igor R. Efimov, Valentin Krinski, Vladmir P. Nikolski
  • Publication number: 20190070424
    Abstract: A method for extinguishing a cardiac arrhythmia utilizes destructive interference of the passing of the reentry wave tip of an anatomical reentry through a depolarized region created by a relatively low voltage electric field in such a way as to effectively unpin the anatomical reentry. Preferably, the relatively low voltage electric field is defined by at least one unpinning shock(s) that are lower than an expected lower limit of vulnerability as established, for example, by a defibrillation threshold test. By understanding the physics of the electric field distribution between cardiac cells, the method permits the delivery of an electric field sufficient to unpin the core of the anatomical reentry, whether the precise or estimated location of the reentry is known or unknown and without the risk of inducting ventricular fibrillation. A number of embodiments for performing the method are disclosed.
    Type: Application
    Filed: August 27, 2018
    Publication date: March 7, 2019
    Inventors: Igor R. Efimov, Valentin Krinski, Vladmir P. Nikolski
  • Patent number: 9855439
    Abstract: High frequency cardiac arrhythmias and fibrillations are terminated by electric field pacing pulses having an order of magnitude less energy than a conventional cardioversion or defibrillation energy. The frequency and number of the pulses are selected based on a frequency analysis of a present high frequency cardiac arrhythmia or fibrillation. The energy of the pulses is selected from 1/400 to ½ of the conventional defibrillation energy, and the amplitude of the electric field pacing pulses are selected such as to activate a multitude of effective pacing sites in the heart tissue per each pacing electrode. The number and locations of the effective pacing sites in the heart tissue are regulated by the amplitude of the electric field pacing pulses, and by an orientation of the electric field of the pulses.
    Type: Grant
    Filed: March 19, 2015
    Date of Patent: January 2, 2018
    Assignee: MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.
    Inventors: Valentin Krinski, Eberhard Bodenschatz, Stefan Luther
  • Patent number: 9233248
    Abstract: For terminating a high frequency arrhythmic electric state of a heart an electric signal representative of the present electric state of the heart is obtained. From the electric signal a dominant frequency of the present electric state is determined, and from the dominant frequency it is determined whether the present electric state of the heart is a high frequency arrhythmic electric state displaying at least one rotating wave. Further, a dominance level indicative of how dominant the dominant frequency is in the high frequency arrhythmic electric state is determined from the electric signal. Depending on the at least one dominant frequency, at least one series of electric pulses at intervals is generated. The electric pulses are applied to the heart starting at a point in time at which the dominance level exceeds a predefined threshold value for the heart being in a determined high frequency arrhythmic electric state.
    Type: Grant
    Filed: October 23, 2014
    Date of Patent: January 12, 2016
    Assignees: MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V.), CORNELL UNIVERSITY
    Inventors: Stefan Luther, Eberhard Bodenschatz, Valentin Krinski, Robert Gilmour, Flavio Fenton
  • Publication number: 20150202451
    Abstract: High frequency cardiac arrhythmias and fibrillations are terminated by electric field pacing pulses having an order of magnitude less energy than a conventional cardioversion or defibrillation energy. The frequency and number of the pulses are selected based on a frequency analysis of a present high frequency cardiac arrhythmia or fibrillation. The energy of the pulses is selected from 1/400 to ½ of the conventional defibrillation energy, and the amplitude of the electric field pacing pulses are selected such as to activate a multitude of effective pacing sites in the heart tissue per each pacing electrode. The number and locations of the effective pacing sites in the heart tissue are regulated by the amplitude of the electric field pacing pulses, and by an orientation of the electric field of the pulses.
    Type: Application
    Filed: March 19, 2015
    Publication date: July 23, 2015
    Inventors: Valentin Krinski, Eberhard Bodenschatz, Stefan Luther
  • Patent number: 8989860
    Abstract: High frequency cardiac arrhythmias and fibrillations are terminated by electric field pacing pulses having an order of magnitude less energy than a conventional cardioversion or defibrillation energy. The frequency and number of the pulses are selected based on a frequency analysis of a present high frequency cardiac arrhythmia or fibrillation. The energy of the pulses is selected from 1/400 to ½ of the conventional defibrillation energy, and the amplitude of the electric field pacing pulses are selected such as to activate a multitude of effective pacing sites in the heart tissue per each pacing electrode. The number and locations of the effective pacing sites in the heart tissue are regulated by the amplitude of the electric field pacing pulses, and by an orientation of the electric field of the pulses.
    Type: Grant
    Filed: February 17, 2012
    Date of Patent: March 24, 2015
    Assignee: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V.
    Inventors: Stefan Luther, Valentin Krinski, Eberhard Bodenschatz
  • Publication number: 20150045846
    Abstract: For terminating a high frequency arrhythmic electric state of a heart an electric signal representative of the present electric state of the heart is obtained. From the electric signal a dominant frequency of the present electric state is determined, and from the dominant frequency it is determined whether the present electric state of the heart is a high frequency arrhythmic electric state displaying at least one rotating wave. Further, a dominance level indicative of how dominant the dominant frequency is in the high frequency arrhythmic electric state is determined from the electric signal. Depending on the at least one dominant frequency, at least one series of electric pulses at intervals is generated. The electric pulses are applied to the heart starting at a point in time at which the dominance level exceeds a predefined threshold value for the heart being in a determined high frequency arrhythmic electric state.
    Type: Application
    Filed: October 23, 2014
    Publication date: February 12, 2015
    Inventors: Stefan Luther, Eberhard Bodenschatz, Valentin Krinski, Robert Gilmour, Flavio Fenton
  • Patent number: 8886309
    Abstract: For terminating a high frequency arrhythmic electric state of a biological tissue an electric signal representative of the present electric state of the biological tissue is obtained. From the electric signal a dominant frequency of the present electric state is determined, and from the dominant frequency it is determined whether the present electric state of the biological tissue is a high frequency arrhythmic electric state. Further, a dominance level indicative of how dominant the dominant frequency is in the high frequency arrhythmic electric state is determined from the electric signal. Depending on the at least one dominant frequency, at least one series of electric pulses at intervals is generated. The electric pulses are applied to the biological tissue starting at a point in time at which the dominance level exceeds a predefined threshold value for the biological tissue being in a determined high frequency arrhythmic electric state.
    Type: Grant
    Filed: December 13, 2013
    Date of Patent: November 11, 2014
    Assignees: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften E.V., Cornell University
    Inventors: Stefan Luther, Eberhard Bodenschatz, Valentin Krinski, Robert Gilmour, Flavio H. Fenton
  • Publication number: 20140107721
    Abstract: For terminating a high frequency arrhythmic electric state of a biological tissue an electric signal representative of the present electric state of the biological tissue is obtained. From the electric signal a dominant frequency of the present electric state is determined, and from the dominant frequency it is determined whether the present electric state of the biological tissue is a high frequency arrhythmic electric state. Further, a dominance level indicative of how dominant the dominant frequency is in the high frequency arrhythmic electric state is determined from the electric signal. Depending on the at least one dominant frequency, at least one series of electric pulses at intervals is generated. The electric pulses are applied to the biological tissue starting at a point in time at which the dominance level exceeds a predefined threshold value for the biological tissue being in a determined high frequency arrhythmic electric state.
    Type: Application
    Filed: December 13, 2013
    Publication date: April 17, 2014
    Inventors: Stefan Luther, Eberhard Bodenschatz, Valentin Krinski, Robert Gilmour, Flavio Fenton
  • Publication number: 20120197328
    Abstract: High frequency cardiac arrhythmias and fibrillations are terminated by electric field pacing pulses having an order of magnitude less energy than a conventional cardioversion or defibrillation energy. The frequency and number of the pulses are selected based on a frequency analysis of a present high frequency cardiac arrhythmia or fibrillation. The energy of the pulses is selected from 1/400 to ½ of the conventional defibrillation energy, and the amplitude of the electric field pacing pulses are selected such as to activate a multitude of effective pacing sites in the heart tissue per each pacing electrode. The number and locations of the effective pacing sites in the heart tissue are regulated by the amplitude of the electric field pacing pulses, and by an orientation of the electric field of the pulses.
    Type: Application
    Filed: February 17, 2012
    Publication date: August 2, 2012
    Inventors: Stefan Luther, Valentin Krinski, Eberhard Bodenschatz
  • Publication number: 20090062877
    Abstract: A multisite heart pacing with adjustable number of pacing sites is realized by using only one lead directly connected to the heart. The number and locations of pacing sites is regulated by increasing the amplitude of pacing pulses delivered by the electric field, and by changing orientation of the electric field. Improved termination of high frequency cardiac arrhythmias and AF is achieved by regulating the number of pacing sites by choosing the pulse energy in the range 1/400-½ DE, where DE is energy of conventional cardioversion/defibrillation. protection against inducing VF by choosing the direction and amplitude of the electric field, and by a proper synchronization with R wave of the ECG. selection of the pacing frequency and amplitude based on the frequency spectrum of a high frequency cardiac arrhythmia.
    Type: Application
    Filed: February 29, 2008
    Publication date: March 5, 2009
    Inventors: Valentin Krinski, Stefan Luther, Eberhard Bodenschatz
  • Publication number: 20060161206
    Abstract: A method for extinguishing a cardiac arrhythmia utilizes destructive interference of the passing of the reentry wave tip of an anatomical reentry through a depolarized region created by a relatively low voltage electric field in such a way as to effectively unpin the anatomical reentry. Preferably, the relatively low voltage electric field is defined by at least one unpinning shock(s) that are lower than an expected lower limit of vulnerability as established, for example, by a defibrillation threshold test. By understanding the physics of the electric field distribution between cardiac cells, the method permits the delivery of an electric field sufficient to unpin the core of the anatomical reentry, whether the precise or estimated location of the reentry is known or unknown and without the risk of inducting ventricular fibrillation. A number of embodiments for performing the method are disclosed.
    Type: Application
    Filed: November 3, 2005
    Publication date: July 20, 2006
    Inventors: Igor Efimov, Valentin Krinski, Vladimir Nikolski